United States · FDA National Drug Code directory

Lamotrigine

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 62332-770_407283a4-871f-4f00-8b49-61129ef9a428
Product NDC: 62332-770
Form: TABLET, ORALLY DISINTEGRATING
Composition / generic term: Lamotrigine
Labeler: Alembic Pharmaceuticals Inc.
Marketing category: ANDA
Marketing start / end (source format): 20260302
Source listing expiry: 20271231

Source-listed ingredients

LAMOTRIGINE — 25 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

2 BLISTER PACK in 1 CARTON (62332-770-15) / 15 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 62332-770-15
30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (62332-770-30) · 62332-770-30

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →